M

Maple Leaf Research | Toronto, Canada

Research site
(Unclaimed)
Location
14 College Street, Suite 403, Toronto, Ontario, Canada

Site insights

Top conditions

Top treatments

Emtricitabine
TDF
Tenofovir Alafenamide
TAF
Rilpivirine
RPV
Tenofovir Disoproxil Fumarate
Bictegravir
FTC
Dolutegravir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 16 total trials

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and...

Enrolling
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Retatrutide

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Enrolling
HIV-1-infection
Drug: Bictegravir
Drug: BIC/LEN FDC

Trial sponsors

Gilead Sciences logo
U
Lilly logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems